Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

Volumn 30, Issue , 2014, Pages 5-10

  Yelken, Berna ^a   Gorgulu, Numan ^a   Gursu, Meltem ^a   Yazici, Halil ^a   Caliskan, Yasar ^a   Telci, Aysegul ^a   Ozturk, Savas ^a   Kazancioglu, Rumeyza ^a   Ecder, Tevfik ^a   Bozfakioglu, Semra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; DIURETIC AGENT; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ADULT; AGED; BLOOD; DRUG EFFECTS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; DIURETICS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84921893655     PISSN: 11978554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)